share_log

港股抗疫板块走弱,康希诺生物跌近3%

The anti-epidemic sector of Hong Kong stocks weakened, and Cansino Biotech fell nearly 3%

Breakings ·  Dec 1, 2022 09:40
The

anti-epidemic sector of Hong Kong stocks weakened. Cansino Biotech fell close to 3%, Junshi Biotech and Shiyao Group fell more than 2%, and Development Pharmaceutical and Fosun Pharmaceutical declined.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment